273 results on '"Pfenniger, Anna"'
Search Results
2. Oxidative stress and atrial fibrillation
3. Validation of the SCALE-CryoAF risk model to predict very late return of atrial fibrillation after cryoballoon ablation
4. A transient, closed-loop network of wireless, body-integrated devices for autonomous electrotherapy.
5. Fully implantable and bioresorbable cardiac pacemakers without leads or batteries.
6. Abstract 17206: Targeted Ablation at Regions of High Oxidative Injury in Persistent Atrial Fibrillation in a Canine Model — A New Electrogram Based Therapeutic Strategy in Atrial Fibrillation?
7. Abstract 14772: Subcutaneous Implantable Cardioverter Defibrillator Extractions: A Single-Healthcare System Analysis of Incidence and Indications
8. Abstract 13924: Combined Gene Therapy Approach Targets Parasympathetic Signaling and Oxidative Stress to Reverse Pre-Existing Persistent Atrial Fibrillation in a Canine Model
9. Abstract 13928: Targeted Atrial Inhibition of Galphaq Signaling With Inhibitory Peptides Attenuates Fibrosis and Inducibility of Atrial Fibrillation in a Canine Heart Failure Model
10. Regions of Highly Recurrent Electrogram Morphology With Low Cycle Length Reflect Substrate for Atrial Fibrillation
11. Correlation between high- and low-voltage impedance measurements following subcutaneous implantable cardioverter-defibrillator implantation
12. Autonomic Dysfunction and Neurohormonal Disorders in Atrial Fibrillation
13. Abstract 15072: Targeted Atrial Inhibition of Parasympathetic Signaling With GiGo Inhibitory Peptides Attenuates Electrical Remodeling and Development of Persistent Atrial Fibrillation in a Canine Model
14. Abstract 14782: Expression of Ngf Shrna in the Left Atrial Appendage Alone is Sufficient to Attenuate Global Left Atrial Parasympathetic and Sympathetic Nerve Sprouting and Resulting Development of Persistent Atrial Fibrillation in a Canine Model
15. Abstract 14784: Outcomes Associated With Implementation of an Intravenous Sotalol Initiation Protocol
16. Abstract 12313: Uncovering Functional and Structural Remodeling Progression of Persistent Atrial Fibrillation Over Time in a Rapid Atrial Pacing Canine Model - New Mechanistic Insights in Persistent Atrial Fibrillation
17. Abstract 10305: A Bioresorbable Pacemaker With Transient Closed-Loop System
18. Use of Atrial Fibrillation Electrograms and T1/T2 Magnetic Resonance Imaging to Define the Progressive Nature of Molecular and Structural Remodeling: A New Paradigm Underlying the Emergence of Persistent Atrial Fibrillation.
19. Pulsed Field Ablation—Will Coronary Spasm Lead to Iconoclasm?
20. Use of Atrial Fibrillation Electrograms and T1/T2 Magnetic Resonance Imaging to Define the Progressive Nature of Molecular and Structural Remodeling – A New Paradigm Underlying the Emergence of Persistent Atrial Fibrillation
21. Abstract 17251: Knockdown of NOX2 Reduces Rotational Drivers in AF - A New Gene Therapy Approach for Atrial Fibrillation?
22. Abstract 17050: Pulmonary Vein Isolation Leads to Decreased Stability of Rotational Activities in Atrial Regions Remote From the Site of Ablation - A New Mechanism by Which Pulmonary Vein Isolation Leads to Beneficial Remodeling in the Atria
23. Abstract 13752: Impact of Pre-ablation Weight Changes on Freedom From Atrial Fibrillation
24. Attenuation of Oxidative Injury With Targeted Expression of NADPH Oxidase 2 Short Hairpin RNA Prevents Onset and Maintenance of Electrical Remodeling in the Canine Atrium: A Novel Gene Therapy Approach to Atrial Fibrillation
25. PO-02-107 CORRELATION BETWEEN HIGH AND LOW VOLTAGE IMPEDANCE MEASUREMENTS FOLLOWING SUBCUTANEOUS ICD IMPLANTATION
26. PO-455617-1 EXPLORING THE INTERPLAY OF FUNCTIONAL AND STRUCTURAL REMODELING PROGRESSION IN ATRIAL FIBRILLATION IN A RAPID ATRIAL PACING CANINE MODEL
27. PO-01-170 PHARMACOLOGICAL AND GENE-THERAPY BASED INHIBITION OF NOX2-GENERATED ROS ATTENUATES DISRUPTION OF MICROTUBULE NETWORK AND EMERGENCE OF TRIGGERED CA WAVES IN ATRIAL MYOCYTES AND IN CHRONIC AF CANINE MODEL
28. BS-452758-4 COMBINED GENE THERAPY APPROACH TARGETS PARASYMPATHETIC SIGNALING AND OXIDATIVE STRESS TO ATTENUATE PERSISTENT ATRIAL FIBRILLATION DEVELOPMENT IN A CANINE MODEL
29. BS-452682-1 EXPLORING THE INTERPLAY OF FUNCTIONAL AND STRUCTURAL REMODELING PROGRESSION IN ATRIAL FIBRILLATION IN A RAPID ATRIAL PACING CANINE MODEL
30. Implementation of an Intravenous Sotalol Initiation Protocol: Implications for Feasibility, Safety, and Length of Stay
31. Esophageal temperature management during cryoballoon ablation for atrial fibrillation
32. Implementation of an Intravenous Sotalol Initiation Protocol: Implications for Feasibility, Safety, and Length of Stay
33. Connexins and Atherosclerosis
34. A transient, closed-loop network of wireless, body-integrated devices for autonomous electrotherapy
35. BS-512-04 TARGETED ATRIAL EXPRESSION OF NGF SHRNA ATTENUATES NEW PARASYMPATHETIC AND SYMPATHETIC NERVE SPROUTING AND RESULTING DEVELOPMENT OF PERSISTENT ATRIAL FIBRILLATION IN A CANINE MODEL - A NOVEL GENE THERAPY APPROACH TO ATRIAL FIBRILLATION
36. BS-400-37 TARGETED ATRIAL EXPRESSION OF NGF SHRNA ATTENUATES NEW PARASYMPATHETIC AND SYMPATHETIC NERVE SPROUTING AND RESULTING DEVELOPMENT OF PERSISTENT ATRIAL FIBRILLATION IN A CANINE MODEL - A NOVEL GENE THERAPY APPROACH TO ATRIAL FIBRILLATION
37. CA-537-03 ESOPHAGEAL TEMPERATURE MANAGEMENT DURING CRYOBALLOON ABLATION FOR ATRIAL FIBRILLATION
38. PO-691-06 UNCOVERING REGIONS OF HIGH OXIDATIVE INJURY IN PERSISTENT ATRIAL FIBRILLATION PATIENTS AND IN A CANINE MODEL WITH ACUTE ADMINISTRATION OF N-ACYTYLCYSTEINE — A NEW THERAPEUTIC TARGET IN PATIENTS WITH PERSISTENT ATRIAL FIBRILLATION?
39. 55 - Gene Therapy for Atrial Fibrillation
40. PO-01-197 TARGETED ATRIAL EXPRESSION OF NOX2 SHRNA ATTENUATES RESPONSIVENESS TO PARASYMPATHETIC BLOCKADE – AN INTERPLAY BETWEEN OXIDATIVE STRESS AND AUTONOMIC REMODELING IN THE DEVELOPMENT OF PERSISTENT ATRIAL FIBRILLATION
41. PO-01-193 DIFFERENTIAL ROLE OF PARASYMPATHETIC AND SYMPATHETIC CARDIAC NERVE ACTIVITY IN PROGRESSION OF ATRIAL FIBRILLATION – A REAL-TIME STUDY OF CARDIAC NERVE ACTIVITY IN A CHRONIC ATRIAL FIBRILLATION CANINE MODEL
42. MP-470551-005 NOX2-GENERATED REACTIVE OXYGEN SPECIES, NOT NLRP3 INFLAMMASOME, IS RESPONSIBLE FOR DISRUPTION OF MICROTUBULE NETWORK AND EMERGENCE OF TRIGGERED CA2+ WAVES IN CANINE ATRIAL MYOCYTES
43. A Case for Regularly Obtaining Nutrition History: Food for Thought.
44. Abstract 12592: Acute Administration of N-Acytylcysteine Leads to Highly Specific Sub-Regional Changes in AF Electrogram Characteristics - A New Way to ‘Uncover’ Regions of High Oxidative Injury in the Fibrillating Atrium?
45. Use of a novel 4D intracardiac echocardiography catheter to guide interventional electrophysiology procedures
46. First-in-Human Use of a Novel 4D Intracardiac Echocardiography Catheter To Guide Interventional Electrophysiology Procedures
47. Unusual Case of Right Ventricular Intravenous Leiomyoma
48. B-PO02-029 REDUCED ATRIAL FIBRILLATION DRIVERS IN RESPONSE TO REACTIVE OXYGEN SCAVENGING - A NOVEL THERAPEUTIC TARGET IN ATRIAL FIBRILLATION?
49. Recent advances in gene therapy for atrial fibrillation
50. Impact of pre‐ablation weight loss on the success of catheter ablation for atrial fibrillation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.